Rimantadine Hydrochloride
Product Images NDC 52959-305

2 FDA label images from H.j. Harkins Company, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Rimantadine Hydrochloride (NDC 52959-305). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by H.j. Harkins Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Chemical Structure (Rimantadine 01)

Chemical Structure (Rimantadine 01)
Chemical structure diagram of Rimantadine Hydrochloride showing the arrangement of atoms, including a cyclohexane ring with attached groups and hydrochloride (HCl) notation.*
FDA Label Image

Principal Display Panel (100 Tablet Bottle Label)

Principal Display Panel (100 Tablet Bottle Label)
Label for Rimantadine Hydrochloride 100 mg tablet manufactured by Global Pharmaceuticals in Philadelphia, PA. The label lists the lot number RMT00GX, expiration date 06/12, and package quantity of 30 tablets. It includes a comparison to Flumadine and identifies the tablet as an orange, oval film-coated tablet. Additional caution and storage instructions are provided, along with multiple smaller label copies for repackaging by H.J. Harkins Co., Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.